MetLife Investment Management’s West Pharmaceutical WST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.8M | Sell |
16,150
-652
| -4% | -$199K | 0.03% | 586 |
|
|
2026
Q1 | $4.21M | Sell |
16,802
-439
| -3% | -$109K | 0.02% | 694 |
|
|
2025
Q4 | $4.74M | Sell |
17,241
-594
| -3% | -$162K | 0.02% | 650 |
|
|
2025
Q3 | $4.68M | Sell |
17,835
-465
| -3% | -$113K | 0.02% | 665 |
|
|
2025
Q2 | $4M | Sell |
18,300
-2,429
| -12% | -$519K | 0.02% | 675 |
|
|
2025
Q1 | $4.64M | Sell |
20,729
-383
| -2% | -$106K | 0.03% | 647 |
|
|
2024
Q4 | $6.92M | Buy |
21,112
+243
| +1% | +$76.5K | 0.04% | 395 |
|
|
2024
Q3 | $6.26M | Sell |
20,869
-599
| -3% | -$183K | 0.04% | 421 |
|
|
2024
Q2 | $7.07M | Buy |
21,468
+1,084
| +5% | +$383K | 0.04% | 335 |
|
|
2024
Q1 | $8.07M | Sell |
20,384
-626
| -3% | -$232K | 0.05% | 292 |
|
|
2023
Q4 | $7.4M | Sell |
21,010
-344
| -2% | -$122K | 0.05% | 305 |
|
|
2023
Q3 | $8.01M | Sell |
21,354
-566
| -3% | -$219K | 0.06% | 255 |
|
|
2023
Q2 | $8.38M | Sell |
21,920
-140
| -0.6% | -$50K | 0.06% | 254 |
|
|
2023
Q1 | $7.64M | Sell |
22,060
-221
| -1% | -$64.6K | 0.06% | 280 |
|
|
2022
Q4 | $5.24M | Sell |
22,281
-445
| -2% | -$105K | 0.04% | 409 |
|
|
2022
Q3 | $5.59M | Sell |
22,726
-260
| -1% | -$79.2K | 0.05% | 358 |
|
|
2022
Q2 | $6.95M | Sell |
22,986
-445
| -2% | -$145K | 0.05% | 281 |
|
|
2022
Q1 | $9.62M | Buy |
23,431
+7,064
| +43% | +$2.77M | 0.06% | 257 |
|
|
2021
Q4 | $7.68M | Sell |
16,367
-342
| -2% | -$147K | 0.06% | 254 |
|
|
2021
Q3 | $7.09M | Sell |
16,709
-407
| -2% | -$172K | 0.06% | 254 |
|
|
2021
Q2 | $6.15M | Sell |
17,116
-543
| -3% | -$179K | 0.05% | 301 |
|
|
2021
Q1 | $4.98M | Sell |
17,659
-295
| -2% | -$84.4K | 0.05% | 389 |
|
|
2020
Q4 | $5.09M | Sell |
17,954
-769
| -4% | -$216K | 0.05% | 353 |
|
|
2020
Q3 | $5.15M | Sell |
18,723
-527
| -3% | -$139K | 0.06% | 310 |
|
|
2020
Q2 | $4.37M | Sell |
19,250
-23,222
| -55% | -$4.56M | 0.05% | 350 |
|
|
2020
Q1 | $6.47M | Hold |
42,472
| – | – | 0.09% | 190 |
|
|
2019
Q4 | $6.38M | Sell |
42,472
-423
| -1% | -$61.6K | 0.07% | 263 |
|
|
2019
Q3 | $6.08M | Sell |
42,895
-642
| -1% | -$88.4K | 0.07% | 270 |
|
|
2019
Q2 | $5.45M | Sell |
43,537
-92,126
| -68% | -$10.9M | 0.06% | 314 |
|
|
2019
Q1 | $14.9M | Buy |
135,663
+90,493
| +200% | +$9.41M | 0.04% | 334 |
|
|
2018
Q4 | $4.43M | Buy |
45,170
+148
| +0.3% | +$16.1K | 0.05% | 332 |
|
|
2018
Q3 | $5.56M | Sell |
45,022
-1,222
| -3% | -$137K | 0.06% | 324 |
|
|
2018
Q2 | $4.59M | Buy |
46,244
+73
| +0.2% | +$6.72K | 0.05% | 345 |
|
|
2018
Q1 | $4.08M | Sell |
46,171
-810
| -2% | -$75.8K | 0.05% | 426 |
|
|
2017
Q4 | $4.64M | Buy |
+46,981
| New | +$4.61M | 0.05% | 372 |
|
Other funds holding WST
GIM
MetLife Investment Management's WST Position: Q2 2026 in Review
MetLife Investment Management reduced its West Pharmaceutical (WST) stake by 3.9% in Q2 2026, selling an estimated $199K and leaving 16,150 shares worth $5.8M. The position accounts for 0.03% of the portfolio, ranked #586.
MetLife Investment Management first reported a position in WST in Q4 2017 and has held it in 35 quarters since. The position peaked at $14.9M in Q1 2019. 834 funds tracked by Wall St. Rank hold WST as of Q2 2026.
- MetLife Investment Management held 16,150 shares of West Pharmaceutical worth $5.8M as of Q2 2026.
- MetLife Investment Management sold 652 West Pharmaceutical shares in Q2 2026, an estimated $199K.
- West Pharmaceutical made up 0.03% of MetLife Investment Management's portfolio in Q2 2026, its #586 holding.
- MetLife Investment Management first reported a position in West Pharmaceutical in Q4 2017 and has held it in 35 quarters since.
- MetLife Investment Management's West Pharmaceutical position peaked at $14.9M in Q1 2019.
- 834 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.
Based on MetLife Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.